NAT13 Antibody - C-terminal region
Artikelnummer:
ASB-ARP48934_T100
Produktübersicht
Artikelname:
NAT13 Antibody - C-terminal region
Artikelnummer:
ASB-ARP48934_T100
Hersteller Artikelnummer:
ARP48934_T100
Alternativnummer:
ASB-ARP48934_T100-25UL,ASB-ARP48934_T100-100UL
Hersteller:
Aviva
Wirt:
Rabbit
Kategorie:
Proteine/Peptide
Applikation:
WB
Spezies Reaktivität:
Bovine, Canine, Equine, Guinea pig, Human, Mouse, Porcine, Rabbit, Rat
Immunogen:
The immunogen is a synthetic peptide directed towards the C terminal region of human NAT13
Alternative Synonym:
SAN, MAK3, NAT5, NAT13, NAT5P, NAT13P, hNaa50p
Produktbeschreibung
NAT13 is a probable catalytic component of the ARD1A-NARG1 complex which displays alpha (N-terminal) acetyltransferase activity.
Produkteigenschaften
Klonalität:
Polyclonal
Konzentration:
1.0 mg/ml
Molekulargewicht:
19kDa
NCBI:
80218
UniProt:
Q9GZZ1
Formulierung:
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Bilder
WB Suggested Anti-NAT13 Antibody Titration: 1.25ug/ml Positive Control: Jurkat cell lysateNAA50 is supported by BioGPS gene expression data to be expressed in Jurkat
Host: Rabbit Target Name: NAT13 Sample Tissue: Human MCF7 Antibody Dilution: 1.0ug/ml
NAT13 antibody - C-terminal region (ARP48934_T100) in Human MCF7 using Western Blot